A village of cancer cells
August 25, 2020
UC research shows it can take cells in different forms or “life stages” to cause cancer to grow and spread.
Advancing our view at the subcellular level
February 25, 2022
University of Cincinnati researchers led by Jiajie Diao and Yujie Sun have developed a new pH probe and imaging technique to provide researchers more information when studying diseases like cancer and Alzheimer's.
Immunotherapy drug bolsters head and neck cancer treatment
February 28, 2022
Researchers led by the University of Cincinnati's Dr. Trisha Wise-Draper led a clinical trial that showed immunotherapy drug pembrolizumab increased survival rates for head and neck cancer patients with intermediate risk.
WFRV/HealthWatch: Lifting brain fog with virtual music therapy
December 14, 2021
The University of Cincinnati's Dr. Soma Sengupta was featured in WFRV's HealthWatch segment highlighting the pilot study of a music therapy app to help lift patients' brain fog.
Identifying risk factors following ICH strokes
March 28, 2022
The University of Cincinnati's Daniel Woo and colleagues recently published a paper in JAMA revealing new insights on how different risk factors following intracerebral hemorrhages can affect patient outcomes.
Medscape: New drug reduces tics in Tourette syndrome patients without major side effects
April 1, 2022
Medscape featured the University of Cincinnati's Dr. Donald Gilbert in an article about a new drug that has been shown to be effective in reducing tics in Tourette syndrome patients while causing less side effects.
MedPage Today: Promising results for living donor transplants
April 5, 2022
The University of Cincinnati's Shimul Shah, MD, was featured in a MedPage Today article highlighting recent research on the success of living donor transplants for patients with unresectable colorectal cancer liver metastases.
Personalized treatments for blood and bone cancer
September 30, 2021
University of Cincinnati researchers have joined a nationwide clinical trial exploring the effectiveness of personalized treatments for patients with acute myelogenous leukemia (AML), a cancer of the blood and bone marrow.